Towards Healthcare Research & Consulting

Healthcare Blogs

Explore the latest healthcare industry blogs, trends, insights, innovations, and expert perspectives across pharmaceuticals, biotechnology, medical devices, healthcare IT, and more.

Concerta - Clinical Role, Long-Acting Methylphenidate, and Market Outlook

Concerta ADHD treatment, long-acting methylphenidate, OROS technology, generic competition, drug shortages, and future market trends.

09 October 2026

Entresto - Clinical Role, Generic Competition, and Market Outlook 

Entresto market trends in 2026, including Novartis sales, generic competition, heart failure treatment, pricing changes and future growth opportunities.

09 October 2026

Prozac (Fluoxetine) - Clinical Role, Generic Competition, and Market Outlook

Prozac market trends, generic fluoxetine competition, approved uses, antidepressant research, pricing trends and future opportunities in mental healthcare.

09 October 2026

Tramadol - Clinical Role, Safety Landscape, and Market Outlook 

Tramadol market outlook, pain treatment applications, opioid safety risks, generic competition, regulatory changes, and future industry trends

09 October 2026

Vyvanse - Clinical Role, Generic Competition, Supply Dynamics, and Market Outlook 

Vyvanse market outlook, lisdexamfetamine generics, ADHD treatment demand, binge eating disorder, drug shortages, and industry trends.

09 October 2026

Zepbound - Clinical Evidence, Expanding Indications, and Market Outlook

Zepbound is reshaping obesity treatment with strong weight loss results, OSA approval, new maintenance data, expanding access and rising competition.

08 October 2026

Zoryve (Roflumilast) - Expanding Dermatology Indications, Clinical Evidence, and Market Outlook

Zoryve is expanding in dermatology with new psoriasis and atopic dermatitis approvals, pediatric use, strong sales growth and international expansion.

08 October 2026

Adderall - Clinical Role, Supply Challenges, Regulatory Landscape, and Market Outlook 

Adderall remains important in ADHD treatment as supply shortages, controlled-substance rules, telehealth policies and generic competition shape the market.

08 October 2026

Lexapro (Escitalopram) - Clinical Role, Recent Evidence, and Market Outlook 

Lexapro and generic escitalopram remain important in depression and anxiety treatment as generic competition, precision medicine and new therapies shape the market.

08 October 2026

Ambroxol Hydrochloride - Clinical Applications, Parkinson’s Research, and Market Outlook

Ambroxol hydrochloride remains a mature mucolytic drug while Parkinson’s research and the ASPro-PD phase 3 trial create new pharmaceutical market opportunities.

08 October 2026

AICAR Beyond Energy Sensing- An AMPK-Modulating Compound 

AICAR interacts with AMPK and its role in research on cellular energy, mitochondrial function, glucose metabolism, and autophagy.

07 October 2026

Singulair - Clinical Role, Regulatory Landscape, and Market Outlook 

Singulair market outlook, clinical use, FDA safety warning, generic competition, regulatory trends, key companies, and future opportunities.

07 October 2026

Rybelsus - Clinical Evidence, Oral Semaglutide Innovation, and Market Outlook 

Rybelsus market outlook, oral semaglutide developments, cardiovascular benefits, regulatory updates, competition, and future opportunities.

07 October 2026

Melatonin - Clinical Evidence, Regulatory Landscape, and Market Outlook 

Melatonin market outlook, sleep aid trends, FDA and EMA regulation, pediatric use, product quality, key companies and future opportunities.

07 October 2026

Gemtesa (Vibegron) - Clinical Evidence, Regulatory Expansion, and Market Outlook

Gemtesa market outlook, vibegron developments, OAB and BPH treatment, COURAGE trial results, competition, sales and future growth.

07 October 2026

Alprazolam - Clinical Role, Regulatory Landscape, Safety Challenges, and Market Outlook

Alprazolam market outlook, Xanax and generic competition, benzodiazepine safety, tapering guidelines, regulation and future trends.

07 October 2026

Radiopharmaceuticals in 2026 Why Targeted Cancer Treatment Is Becoming a Major Pharma Trend 

Radiopharmaceuticals market outlook, targeted cancer therapy, radioligand treatments, Actinium 225, key companies, challenges and future trends.

07 October 2026

Rocephin Injection: Ceftriaxone’s Clinical Role, Market Position, and Future Outlook

Explore Rocephin Injection, ceftriaxone uses, key companies, generic competition, antimicrobial resistance, supply challenges, and future outlook.

06 October 2026

Misoprostol: Clinical Applications, Regulatory Developments, Supply Dynamics, and Market Outlook

Explore the misoprostol market, including reproductive-health uses, WHO guidelines, key manufacturers, quality concerns, procurement, and future outlook.

06 October 2026

Ubrelvy: Ubrogepant’s Clinical Role, Commercial Performance, and Market Outlook

Explore the Ubrelvy market, including ubrogepant uses, clinical evidence, AbbVie sales, CGRP competition, patents, generic entry, and future outlook.

06 October 2026

Showing 1 to 20 of 95 companies